Project Pragmatica: US FDA’s OCE Initiative Aims To Encourage Simple Clinical Trials
Executive Summary
OCE Director Richard Pazdur says idea for the latest initiative stemmed from a clinical trial in lung cancer that he thought only needed to measure the impact on overall survival.
You may also be interested in...
US FDA Drugs Center Launches Clinical Trial Innovation Hub With Demonstration Projects
CDER’s Center for Clinical Trial Innovation (C3TI) will support innovative clinical trial approaches designed to improve the quality and efficiency of drug development and regulatory decision-making. The initiative includes demonstration projects on Bayesian analyses, selective safety data collection and point-of-care trials.
US FDA’s Pazdur Wants Clinicians To Help Set Oncology Research Agenda
Oncology Center of Excellence director said clinical trial participation may increase if the research questions are ‘significant to answer.’
US FDA, NCI Collaboration Deepens To Include Clinical Trial Innovation ‘Think Tank’
Former NCI Director Monica Bertagnolli, who now is head of the NIH, said FDA, NCI and National Clinical Trials Network officials are working on potential clinical trial system innovations.